March 2, 2018 / 7:42 AM / 4 months ago

BRIEF-Verona Pharma Says Positive Top-Line Data From Phase 2A Trial With Rpl554

March 2 (Reuters) - Verona Pharma Plc:

* ‍REG-VERONA PHARMA REPORTS POSITIVE TOP-LINE DATA FROM PHASE 2A TRIAL WITH RPL554 IN CYSTIC FIBROSIS PATIENTS​

* ‍AWAIT RESULTS OF ONGOING PHASE 2B TRIAL FOR MAINTENANCE TREATMENT OF COPD, ANTICIPATE REPORTING TOP-LINE DATA EARLY IN Q2 OF 2018​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below